In colorectal cancer, elevated ROS levels can disrupt the protein–protein interactions between E-cadherin and β-catenin, leading to the activation of Wnt/β-catenin signaling and subsequent tumor growth [54]. Here, CDH1 is linked to colorectal cancer.